Skip to main content

chlorzoxazone

Generic: CHLORZOXAZONE·Brand: CHLORZOXAZONE, PARAFLEX, PARAFON FORTE DSC, STRIFON FORTE DSC

chlorzoxazone: sourced relationships with 1 company · 1 FDA decision.

chlorzoxazone evidence translation

What we can confirm

What it means

Source-backed records connect chlorzoxazone to RDY; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could chlorzoxazone → RDY affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (1)
CompanyDated record stage
DR REDDYS LABORATORIES LTD (RDY)
Reported 2020-07-21 · Current development: unknownSource
Approved
FDA Decisions1 records
ApprovalINDICATIONS AND USAGE Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man.(RDY)FDA ↗
ANDA211849UNKNOWNStandardOralTablet

Frequently asked questions

Which companies have sourced relationships with chlorzoxazone?

chlorzoxazone has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD.

What is chlorzoxazone's latest FDA decision?

The most recent tracked FDA decision for chlorzoxazone is Approval for INDICATIONS AND USAGE Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man., dated July 21, 2020.